Equities research analysts expect that U.S. Physical Therapy, Inc. (NYSE:USPH) will announce sales of $118.08 million for the current quarter, Zacks Investment Research reports. Three analysts have made estimates for U.S. Physical Therapy’s earnings. The lowest sales estimate is $116.40 million and the highest is $120.12 million. U.S. Physical Therapy posted sales of $122.11 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 3.3%. The company is scheduled to issue its next earnings report before the market opens on Thursday, February 25th.

On average, analysts expect that U.S. Physical Therapy will report full-year sales of $423.58 million for the current year, with estimates ranging from $421.90 million to $425.63 million. For the next financial year, analysts expect that the firm will report sales of $476.59 million, with estimates ranging from $473.77 million to $481.70 million. Zacks’ sales calculations are an average based on a survey of sell-side research firms that that provide coverage for U.S. Physical Therapy.

Shares of USPH stock opened at $136.88 on Friday. The business’s fifty day moving average price is $130.84 and its 200 day moving average price is $105.51. U.S. Physical Therapy has a 1-year low of $45.13 and a 1-year high of $141.77. The firm has a market capitalization of $1.76 billion, a PE ratio of 58.25 and a beta of 1.45. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.89 and a quick ratio of 0.89.

In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 6,000 shares of the company’s stock in a transaction on Friday, December 4th. The stock was sold at an average price of $106.67, for a total value of $640,020.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Bernard A. Harris, Jr. sold 5,000 shares of the company’s stock in a transaction on Friday, November 27th. The shares were sold at an average price of $107.00, for a total value of $535,000.00. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company’s stock.

Institutional investors have recently bought and sold shares of the business. Vantage Consulting Group Inc acquired a new stake in U.S. Physical Therapy in the fourth quarter valued at $27,000. Wolff Wiese Magana LLC acquired a new stake in shares of U.S. Physical Therapy during the fourth quarter valued at $35,000. Nisa Investment Advisors LLC acquired a new stake in shares of U.S. Physical Therapy during the third quarter valued at $39,000. Veriti Management LLC acquired a new stake in shares of U.S. Physical Therapy during the fourth quarter valued at $68,000. Finally, Point72 Hong Kong Ltd boosted its stake in shares of U.S. Physical Therapy by 552.1% during the third quarter. Point72 Hong Kong Ltd now owns 952 shares of the company’s stock valued at $83,000 after acquiring an additional 806 shares during the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: Understanding Average Daily Trade Volume

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.